AMAG Pharmaceuticals, Inc. to Participate in the 14th Annual Needham Healthcare Conference
April 08 2015 - 8:00AM
AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that Frank
Thomas, AMAG's president and chief operating officer, will present
at the 14th Annual Needham Healthcare Conference on Wednesday,
April 15, 2015 at 8:00 a.m. ET in New York. The session will
include a company presentation followed by a question and answer
session, in which the company's financial results, business update,
regulatory status, and growth prospects will be discussed.
A live webcast of the presentation will be accessible through
the Investors section of the company's website at
www.amagpharma.com. Following the conference, the webcast will be
archived on the AMAG Pharmaceuticals, Inc. website for 30 days.
About AMAG
AMAG Pharmaceuticals, Inc. is a specialty pharmaceutical company
with a focus on maternal health, anemia and cancer supportive care.
The primary goal of AMAG is to bring to market therapies that
provide clear benefits and improve patients' lives. In addition to
continuing to pursue opportunities to make new advancements in
patients' health and to enhance treatment accessibility, AMAG
intends to continue to expand and diversify its portfolio through
the in-license or purchase of additional pharmaceutical products or
companies. For additional company information, please visit
www.amagpharma.com.
CONTACT: AMAG Pharmaceuticals, Inc. Contact:
Linda Lennox
Vice President, Investor Relations & Corporate Communications
617-498-2846
AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart
From Mar 2024 to Apr 2024
AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart
From Apr 2023 to Apr 2024